Outset Medical (OM) Net Cash Flow (2019 - 2026)

Outset Medical (OM) has reported Net Cash Flow for 8 consecutive years, with $4.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Cash Flow rose 112.22% year-over-year to $4.4 million in Q2 2026; TTM through Jun 2026 was -$4.1 million, a 338.47% decrease from a year earlier, with the FY2025 full-year figure at -$88.5 million, down 259.46% from the prior year.
• Net Cash Flow was $4.4 million for Q2 2026 at Outset Medical, up from -$4.4 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $90.7 million in Q4 2024 and troughed at -$68.0 million in Q1 2022.
• A 5-year average of -$9.8 million and a median of -$4.5 million in 2024 frame the typical range for Net Cash Flow.
• The widest YoY moves for Net Cash Flow: up 28315.0% in 2024, down 4924.18% in 2024.
• Over 5 years, Net Cash Flow stood at -$20.7 million in 2022, then surged by 255.95% to $32.2 million in 2023, then jumped by 181.66% to $90.7 million in 2024, then tumbled by 101.03% to -$931000.0 in 2025, then soared by 577.23% to $4.4 million in 2026.
• The last three Net Cash Flow figures came in at $4.4 million (Q2 2026), -$4.4 million (Q1 2026), and -$931000.0 (Q4 2025), per Business Quant data.